colchicine placebo

DRUG3 trials

Sponsors

Montreal Heart Institute, Hamilton Health Sciences Corporation

Conditions

Cardiovascular DiseasesCoronary Artery DiseaseDiabete Type 2Heart FailureMyocardial Infarction

Phase 3

Colchicine Cardiovascular Outcomes Trial (COLCOT)

CompletedNCT02551094

Montreal Heart InstituteCoronary Artery Disease, Myocardial Infarction

Start: 2015-12-04End: 2019-07-17Updated: 2020-10-19

COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes

RecruitingNCT05633810

Montreal Heart InstituteCardiovascular Diseases, Diabete Type 2

Start: 2022-12-21End: 2027-12-01Target: 10000Updated: 2026-03-10

COLchicine and Thiamine in Heart Failure Due to Ischemic Heart Disease

RecruitingNCT05873881

Hamilton Health Sciences CorporationHeart Failure

Start: 2024-01-29End: 2027-06-30Target: 2500Updated: 2025-06-19

Related Papers

Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

European Heart Journal2020-08-04298 citations

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction

New England Journal of Medicine2019-11-162756 citations